• Can changes in EEG improve neuropathic pain treatments - read Oct newsletter.
  • Nine posters ready to reveal at the SfN virtual conference 8-11 Nov, booth 1818.
  • Joined-up preclinical and clinical trials to advance psilocybin drug development
  • Transpharmation joins HaPpY team to help break the vicious cycle of chronic pain & mood disorders, see News for details
  • Announcing new premises in Poland with a focus on neuropsychiatric disorders...
  • New state-of-the-art premises at Discovery Park, Kent
 

Conferences

All the latest conference updates; those that we are attending and the studies that we are presenting

With preclinical – clinical transition being the largest failure risk in CNS therapeutics development, join us at hubXchange’s CNS Therapeutics East Coast Virtual roundtable meeting, where senior drug developers from pharma and biotech share experiences and discuss the future research landscape.

Join us at 13.00 EST to hear Transpharmation’s Scientific Lead Sandor Kantor present ‘Changes in Brain Oscillatory Activity Might Predict the Efficacy of Therapeutics in Neuropsychiatric Disorders’. His 30 minute slot will cover the following:

  • Disrupted sleep and abnormal brain oscillations are common early features of many neuropsychiatric disorders. Since sleep and EEG abnormalities often precede the clinical onset of these diseases, their possible involvement in the pathophysiological process is considered
  • Medications used for symptomatic treatment of neuropsychiatric disorders often affect sleep and brain oscillatory activity. Furthermore, altering brain oscillatory activity by non-pharmacological means can improve the symptoms of the diseases
  • Thus, the potential mechanistic relationship between changes in brain oscillatory activity and the pathophysiological process in these disorders will be discussed alongside with potential novel therapeutic targets

Find details of our sleep/wake work here

For more information on the speaker faculty, topics of discussion and registration process, please visit
https://www.hub-xchange.com/cns-therapeutics-xchange-east-coast-2021/#anchor1

 

Start a Conversation

preclinical +44 (0)203 633 2807

clinical trials +353 (0)1896 42 60

clinical research +48 515 244 120

EEG contact@transpharmation.co.uk


Copyright ©2021 Transpharmation Ltd. Website created by Identity Ipswich Web Design